Skip to main content

Table 3 Univariate and multivariate logistic regression analysis

From: Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy

Variables

Univariate

Multivariate

OR (95% CI)

p-value

OR (95% CI)

p-value

Gender

 Male

Reference

–

 Female

0.7 (0.5–1)

0.108

–

–

Age (years)

  ≤ 50

Reference

–

  > 50

0.8 (0.5–1.2)

0.318

–

–

All drugs prescribed

  ≤ 7

Reference

Reference

  > 7

3.6 (2.5–5.3)

0.0001

3.5 (2.2–5.5)

0.0001

Anticancer drugs

  ≤ 2

Reference

Reference

  ≥ 3

4.7 (3–7.4)

0.0001

3.6 (2.1–6.2)

0.0001

Supportive care drugs

  ≤ 3

Reference

Reference

  > 3

1.9 (1.3–2.9)

0.001

0.6 (0.3–1.2)

0.161

Hospitalization status

 Ambulatory

Reference

Reference

 Hospitalized

1.8 (1.2–2.6)

0.004

1.3 (0.8–2)

0.327

Cancer type

 Hematological malignancy

Reference

Reference

 Solid malignancy

0.4 (0.3–0.6)

0.0001

0.7 (0.4–1.1)

0.173

Metastasis

 Present

Reference

–

 Absent

1.5 (0.9–2.4)

0.07

–

–

Treatment type

 Cytotoxic agents

Reference

Reference

 Combination drugsa

2.1 (1.3–3.4)

0.003

0.7 (0.4–1.3)

0.343

Treatment intent

 Curative

Reference

–

 Palliative

1.6 (0.8–3.3)

0.218

–

–

  1. - pDDIs Potential drug–drug interactions; OR Odds ratio; CI Confidence interval
  2. -Hosmer–Lemeshow goodness-of-fit test: p = 0.3
  3. -aCombination means regimen comprising of cytotoxic, hormonal or monoclonal agents in combination